Renub Research has recently published a report named "Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030," providing a detailed industry analysis that consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the recent growth in the Non-Invasive Prenatal Testing (NIPT) Market.

1. Non-Invasive Prenatal Testing
Market size is anticipated to
reach US$ 9.37 Billion by 2030
Base Year: 2022
Market Research & Advisory

2. 2
2
Non-Invasive Prenatal Testing Market
Renub Research has recently published a report named "Non-Invasive Prenatal Testing Market: Global Industry
Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030," providing a detailed industry analysis that
consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the
recent growth in the Non-Invasive Prenatal Testing (NIPT) Market.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/non-
invasive-prenatal-testing-market-p.php
A CAGR of 13.60% is expected for the Non-Invasive Prenatal Testing Market between 2022 and 2030.The
development of technology over the years has made it possible to identify more minor genetic anomalies, including
numerous single-gene disorders. The non-invasive prenatal test (NIPT) is the most recent advancement in the field
of prenatal diagnosis. It is intended to assist professionals in the management of pregnancy and its counselling as
well as prospective parents in making deliberate and well-informed decisions regarding their unborn child.
2
https://www.renub.com

3. 3
3
Non-Invasive Prenatal Testing Market
Prenatal diagnosis is evolving all over the world thanks to non-invasive prenatal testing (NIPT). It offers high
specificity and sensitivity for detecting common aneuploidies. As a result, it has decreased the frequency of invasive
procedures and the risk of miscarriage that goes along with them. Cell-free fetal DNA (cffDNA), which is obtained
from a maternal peripheral blood sample, serves as the foundation for NIPT.
The performance of NIPT has recently improved, and new applications have been made possible thanks to
advanced laboratory detection and purification technology. The development of Next Generation Sequencing (NGS)
into clinical practice has increased the sensitivity of NIPT for aneuploidy screening. It has also made it possible to
identify and research the fetal genome from maternal plasma. Fetal Whole Exome Sequencing (WES) enables non-
invasive prenatal diagnosis of inherited monogenic disorders and can identify the underlying cause of fetal
anomalies with a normal karyotype.
The landscape of prenatal screening has changed significantly since non-invasive prenatal testing (NIPT) for the
detection of fetal aneuploidies was introduced into clinical practice in 2011. More than 10 million people take the test
annually, which is accessible in more than 60 countries. The rapid adoption of NIPT was facilitated by demand from
expectant mothers and medical professionals, technological advancements, and financial incentives.
3
https://www.renub.com

4. 4
4
Non-Invasive Prenatal Testing Market
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=non-
invasive-prenatal-testing-market-p.php
Cell-free DNA tests, which are becoming more and more popular, are anticipated to rule the Non-Invasive
Prenatal Testing Market in the upcoming years
CfDNA tests in maternal plasma are the most widely used option on the global NIPT market because of their high
accuracy, dependability, and sensitivity of over 99% for detecting trisomy 21. They are accessible as early as 10
weeks of pregnancy and do not require invasive procedures like amniocentesis, which appeals to many pregnant
women. They can also be used by a wider variety of expectant mothers due to their affordability. These benefits
have made cfDNA tests more and more well-liked, and they are anticipated to take over the global NIPT market in
the future.
Method – Non-Invasive Prenatal Testing (NIPT) Market has been covered from 4 viewpoints:
1. Ultrasound detection 2. Biochemical screening tests
3. Cell-free DNA in maternal plasma tests 4. Others
4
https://www.renub.com

5. 5
5
Non-Invasive Prenatal Testing Market
Enzyme-Linked Immunosorbent Assay (ELISA) Kits, are the global Non-Invasive Prenatal Testing (NIPT)
market's fastest-growing subsegment worldwide.
The versatility of ELISA kits in identifying a variety of analytes, such as antibodies, antigens, hormones, and
enzymes, makes them appropriate for a variety of clinical and research applications. Their high sensitivity and
specificity guarantee accurate results and reliable detection of even minute amounts of analyte. ELISA kits are also
user-friendly, making them accessible to labs with limited resources, and their cost-effectiveness makes them a
good option for labs on a tight budget. Moreover, the market is expanding as a result of the rising demand for point-
of-care (POC) testing. Due to their simplicity of use and suitability for testing with minimal equipment, ELISA kits are
a good choice for POC testing.
Technology – Non-Invasive Prenatal Testing Market has been covered from 3 viewpoints:
1. ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits)
2. Next Generation Sequencing Systems
3. Microarray Analysis
5
https://www.renub.com

6. 6
6
Non-Invasive Prenatal Testing Market
The high- and average-risk segments are expected to continue to dominate
the Non-Invasive Prenatal Testing (NIPT) Market in the years to come.
High-risk pregnancies have a higher prevalence of chromosomal abnormalities,
which increases the risk of such abnormalities due to factors like maternal age
and family history. The high chromosomal abnormality detection accuracy of
NIPT in high-risk pregnancies is advantageous to both pregnant women and
medical professionals. More pregnant women, including those at high or average
risk, can now access NIPT at an affordable price thanks to its increased
accessibility and falling price.
Risk Type – Non-Invasive Prenatal Testing Market has been covered from 2
viewpoints:
1. High & Average risk 2. Low risk
6
https://www.renub.com

7. 7
7
Non-Invasive Prenatal Testing Market
The majority of global Non-Invasive Prenatal testing businesses are
diagnostic facilities.
Diagnostic centers have an advantage in the global NIPT market due to
their expertise, experience, and access to cutting-edge technology. They
effectively carry out NIPT with qualified specialists acquainted with its
subtleties. Furthermore, they provide practical one-stop services that make
it simple for expectant women to get tested and receive results in a timely
manner, fostering patient trust thanks to their track record of delivering
accurate and dependable results and accreditation by regulatory bodies.
End-User – Non-Invasive Prenatal Testing (NIPT) Market has been
covered from 3 viewpoints:
1. Specialty Centers
2. Hospitals
3. Diagnostic Centers
7
https://www.renub.com

8. 8
8
Non-Invasive Prenatal Testing Market
The United States is expected to keep holding a
commanding share in the Non-Invasive Prenatal Testing
(NIPT) Market over the coming years.
The prevalence of chromosomal abnormalities is higher in
the nation as a result of elements like maternal age, family
history, and race. Due to media coverage, marketing
initiatives, and insurance reimbursement policies, NIPT is
also well-known among pregnant women and medical
professionals. A favorable regulatory environment and the
availability of numerous NIPT companies both support the
market's expansion. For the development and interpretation
of NIPT, the US also has the necessary technological and
clinical capabilities.
8
https://www.renub.com

9. 9
9
Non-Invasive Prenatal Testing Market
Countries – Non-Invasive Prenatal Testing (NIPT) Market has been covered from 27 viewpoints:
1. North America
1.1 United States 1.2 Canada
2. Europe
2.1 France 2.2 Germany 2.3 Italy 2.4 Spain
2.5 United Kingdom 2.6 Belgium 2.7 Netherlands 2.8 Switzerland
2.9 Turkey
3. Asia Pacific
3.1 China 3.2 Japan 3.3 India 3.4 Australia
3.5 South Korea 3.6 Thailand 3.7 Malaysia 3.8 Indonesia
3.9 Philippines
9
https://www.renub.com

10. 10
10
Non-Invasive Prenatal Testing Market
4. Latin America
4.1 Brazil 4.2 Mexico 4.3 Argentina
5. Middle East & Africa
5.1 South Africa 5.2 Saudi Arabia 5.3 UAE
6. Rest of the World
Competitive Landscape.
F. Hoffman-La Roche, Eurofins Scientific, Illumina, Natera Inc., Revvity Inc., Thermo Fisher Scientific, Quest
Diagnostics, and Agilent Technologies are some of the top competitors in the global non-invasive prenatal testing
market.
10
https://www.renub.com

11. 11
11
Non-Invasive Prenatal Testing Market
All companies have been covered from 3 viewpoints:
• Overview • Recent Development • Revenue
Company Analysis:
1. F. Hoffman-La Roche
2. Eurofins Scientific
3. Illumina
4. Natera Inc.
5. Revvity Inc.
6. Thermo Fisher Scientific
7. Quest Diagnostics
8. Agilent Technologies
11
https://www.renub.com

12. S
O U T
A U
B
12
https://www.renub.com
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in
Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy,
organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000
syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to
EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings
and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research